Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism*; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D051381:Rats; D011954:Receptors, Dopamine / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*; D013134:Spiperone / Q000378:metabolism; D013347:Subcellular Fractions / Q000378:metabolism; D013469:Sulpiride / Q000378:metabolism; D013574:Synaptosomes / Q000378:metabolism
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D011955:Receptors, Drug; D013134:Spiperone; D013469:Sulpiride